Credence MedSystems

Credence MedSystems is a private medical device company founded in 2010, headquartered in Menlo Park, California. It provides innovative, IP-protected injectable drug delivery systems, including syringe systems, dual-chamber devices, metered dosing, and connected health solutions, to solve complex formulation, usability, and supply chain challenges for drug manufacturers. The company is in a revenue-generating stage, partnering with global pharmaceutical leaders, and is recognized in the industry for its award-winning technology platform that aims to improve safety, adherence, and sustainability in medication delivery.

A modular platform of innovative injectable drug delivery systems including the Companion Syringe, Dual Chamber systems for reconstitution, Metered Dosing systems, and enabling technologies for connectivity and specialized needs. The platform is designed for 'Innovation Without Change,' allowing integration with existing pharmaceutical manufacturing processes and components.

Credence competes in the injectable drug delivery device market against large, diversified players like BD, Gerresheimer, West Pharmaceutical Services, and Schott, as well as specialized innovators. Its differentiation lies in its comprehensive, modular platform and its strategy of enabling innovation without forcing changes to clients' established supply chains and processes.